The scientific advisory board will now comprise of four leading clinical researchers with multi-disciplinary expertise to support clinical trials and product expansionSALT LAKE CITY, Oct. 22, 2024 ...
CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and ...